Guo Meng
Directeur/Bestuurslid bij SSY GROUP LIMITED
Vermogen: 12 M $ op 30-04-2024
Actieve functies van Guo Meng
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SSY GROUP LIMITED | Directeur/Bestuurslid | 27-08-2021 | - |
| Corporate Officer/Principal | - | - | |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Bestuurslid | - | - |
| Hebei Guolong Pharmaceutical Co., Ltd. | Directeur/Bestuurslid | - | - |
Loopbaan van Guo Meng
Eerdere bekende functies van Guo Meng
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | 01-01-2001 | - | |
| President | - | - |
Opleiding van Guo Meng
| Lanzhou University | Undergraduate Degree |
| Beijing University of Technology | Graduate Degree |
Statistieken
Internationaal
| China | 5 |
| Hongkong | 2 |
Operationeel
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Hebei Guolong Pharmaceutical Co., Ltd. |